These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16396509

  • 21. Practical points in urinary proteomics.
    Thongboonkerd V.
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [Abstract] [Full Text] [Related]

  • 22. Human saliva proteome analysis and disease biomarker discovery.
    Hu S, Loo JA, Wong DT.
    Expert Rev Proteomics; 2007 Aug; 4(4):531-8. PubMed ID: 17705710
    [Abstract] [Full Text] [Related]

  • 23. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S, Yen Y, Ann D, Wong DT.
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [Abstract] [Full Text] [Related]

  • 24. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L, Ignatchenko A, Evangelou AI, Agochiya M, Brown KA, St Onge P, Kireeva I, Schmitt-Ulms G, Brown TJ, Murphy J, Rosen B, Shaw P, Jurisica I, Kislinger T.
    J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Approaches to dimensionality reduction in proteomic biomarker studies.
    Hilario M, Kalousis A.
    Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
    [Abstract] [Full Text] [Related]

  • 27. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F, Martín-Ventura JL, Duran MC, Barderas MG, Blanco-Colio L, Dardé VM, Mas S, Meilhac O, Michel JB, Tuñón J, Egido J.
    J Proteome Res; 2005 Mar; 4(4):1181-91. PubMed ID: 16083268
    [Abstract] [Full Text] [Related]

  • 28. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT.
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prevalidation of potential protein biomarkers in toxicology using iTRAQ reagent technology.
    Glückmann M, Fella K, Waidelich D, Merkel D, Kruft V, Kramer PJ, Walter Y, Hellmann J, Karas M, Kröger M.
    Proteomics; 2007 May; 7(10):1564-74. PubMed ID: 17443845
    [Abstract] [Full Text] [Related]

  • 31. Comparative proteome analysis of serum from acute pulmonary embolism rat model for biomarker discovery.
    Li SQ, Yun J, Xue FB, Bai CQ, Yang SG, Que HP, Zhao X, Wu Z, Wang Y, Liu SJ.
    J Proteome Res; 2007 Jan; 6(1):150-9. PubMed ID: 17203959
    [Abstract] [Full Text] [Related]

  • 32. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D.
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [Abstract] [Full Text] [Related]

  • 33. High-performance proteomics as a tool in biomarker discovery.
    Meyer HE, Stühler K.
    Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
    [Abstract] [Full Text] [Related]

  • 34. Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury.
    Boutté AM, Yao C, Kobeissy F, May Lu XC, Zhang Z, Wang KK, Schmid K, Tortella FC, Dave JR.
    Electrophoresis; 2012 Dec; 33(24):3693-704. PubMed ID: 23161467
    [Abstract] [Full Text] [Related]

  • 35. The role of capillary electrophoresis-mass spectrometry to proteome analysis and biomarker discovery.
    Ahmed FE.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul 15; 877(22):1963-81. PubMed ID: 19525156
    [Abstract] [Full Text] [Related]

  • 36. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK, Busch CM, Felix CA, Blair IA.
    J Proteome Res; 2006 Oct 15; 5(10):2743-53. PubMed ID: 17022645
    [Abstract] [Full Text] [Related]

  • 37. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.
    Chang Gung Med J; 2008 Oct 15; 31(5):417-30. PubMed ID: 19097588
    [Abstract] [Full Text] [Related]

  • 38. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA, Hanash S.
    Breast Cancer Res; 2006 Oct 15; 8(6):217. PubMed ID: 17184556
    [Abstract] [Full Text] [Related]

  • 39. Proteomics technologies in endometriosis.
    Ferrero S, Gillott DJ, Remorgida V, Ragni N, Venturini PL, Grudzinskas JG.
    Expert Rev Proteomics; 2008 Oct 15; 5(5):705-14. PubMed ID: 18937560
    [Abstract] [Full Text] [Related]

  • 40. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B, Ball G, Rees R.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.